-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
The Discipline Inspection Commission of Hebei Province visited Shisi Pharmaceutical to conduct research and provide guidance on the implementation of epidemic prevention and control measures as well as production assurance.
Category:
Time：2020-01-30
On the afternoon of January 29, relevant officials from the Hebei Provincial Commission for Discipline Inspection conducted an in-depth investigation and provided guidance at Shijiazhuang Fourth Pharmaceutical regarding the implementation of epidemic prevention and control measures and the assurance of production and supply.
On the afternoon of January 29, relevant officials from the Hebei Provincial Commission for Discipline Inspection conducted an in-depth investigation and provided guidance at Shijiazhuang No. 4 Pharmaceutical Company on the implementation of epidemic prevention and control measures as well as the assurance of production and supply. “We must support enterprises in accelerating production, rigorously implementing and refining epidemic prevention and control measures, and ensuring that enterprises remain free of outbreaks while guaranteeing a stable supply of products.”
Relevant officials from the Provincial Commission for Discipline Inspection carefully inquired of Wu Hengyao, General Manager of Shijiazhuang Sihua Pharmaceutical, about the implementation of the company’s epidemic prevention and control measures and the assurance of production factors. The officials from the Provincial Commission for Discipline Inspection highly praised the company for actively implementing epidemic prevention and control measures, overcoming difficulties, stepping up production, effectively organizing the supply of emergency medicines, and providing support to the frontline of epidemic prevention and control—thus fulfilling its social responsibility and demonstrating, at a critical moment, the pharmaceutical enterprise’s mission and sense of responsibility.
Relevant officials from the provincial Commission for Discipline Inspection stated that they must address the urgent needs of manufacturing enterprises, play their role, and support enterprises in maintaining normal production, resolutely winning the battle against the epidemic.
Relevant officials from the Discipline Inspection Commission of Shijiazhuang City and the Discipline Inspection Working Committee of Shijiazhuang High-tech Zone participated in the research.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license